{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:17:23Z","timestamp":1790702243974,"version":"4.1.0"},"reference-count":143,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPR"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Juvenile dermatomyositis is the most common inflammatory myopathy in the\npediatric age group and a major cause of mortality and morbidity in individuals with childhood rheumatic\ndiseases. Mounting evidence suggests that early diagnosis and timely aggressive treatment are associated\nwith better outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The purpose of this article is to provide readers with an update on the evaluation, diagnosis,\nand the treatment of juvenile dermatomyositis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A PubMed search was performed in Clinical Queries using the key term \u201cjuvenile dermatomyositis\u201d\nin the search engine. The search strategy included meta-analyses, randomized controlled trials,\nclinical trials, observational studies, and reviews. The search was restricted to English literature. The information\nretrieved from the above search was used in the compilation of the present article.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Juvenile dermatomyositis is a chronic autoimmune inflammatory condition characterized by systemic\ncapillary vasculopathy that primarily affects the skin and muscles with possible involvement of\nother organs. In 2017, the European League Against Rheumatism (EULAR) and the American College\nof Rheumatology (ACR) developed diagnostic criteria for juvenile idiopathic inflammatory myopathies\nand juvenile dermatomyositis. In the absence of muscle biopsies which are infrequently performed in\nchildren, scores (in brackets) are assigned to four variables related to muscle weakness, three variables related\nto skin manifestations, one variable related to other clinical manifestations, and two variables related\nto laboratory measurements to discriminate idiopathic inflammatory myopathies from non-idiopathic\ninflammatory myopathies as follows: objective symmetric weakness, usually progressive, of the proximal\nupper extremities (0.7); objective symmetric weakness, usually progressive, of the proximal lower\nextremities (0.8); neck flexors relatively weaker than neck extensors (1.9); leg proximal muscles relatively\nweaker than distal muscles (0.9); heliotrope rash (3.1); Gottron papules (2.1); Gottron sign (3.3); dysphagia\nor esophageal dysmotility (0.7); the presence of anti-Jo-1 autoantibody (3.9); and elevated serum\nlevels of muscle enzymes (1.3). In the absence of muscle biopsy, a definite diagnosis of idiopathic inflammatory\nmyopathy can be made if the total score is \u22657.5. Patients whose age at onset of symptoms is\nless than 18 years and who meet the above criteria for idiopathic inflammatory myopathy and have a heliotrope\nrash, Gottron papules or Gottron sign are deemed to have juvenile dermatomyositis. The mainstay\nof therapy at the time of diagnosis is a high-dose corticosteroid (oral or intravenous) in combination\nwith methotrexate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For mild to moderate active muscle disease, early aggressive treatment with high-dose oral\nprednisone alone or in combination with methotrexate is the cornerstone of management. Pulse intravenous\nmethylprednisolone is often preferred to oral prednisone in more severely affected patients, patients\nwho respond poorly to oral prednisone, and those with gastrointestinal vasculopathy. Other steroid-sparing\nimmunosuppressive agents such as cyclosporine and cyclophosphamide are reserved for patients\nwith contraindications or intolerance to methotrexate and for refractory cases, as the use of these agents\nis associated with more adverse events. Various biological agents have been used in the treatment of juvenile\ndermatomyositis. Data on their efficacy are limited, and their use in the treatment of juvenile dermatomyositis\nis considered investigational.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1573396317666210426105045","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:42:32Z","timestamp":1619484152000},"page":"273-287","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-6971","authenticated-orcid":true,"given":"Alexander K.C.","family":"Leung","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The University of Calgary, Alberta Children\u2019s Hospital, Calgary, Alberta,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-3369","authenticated-orcid":true,"given":"Joseph M.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Department of Dermatology and Skin Sciences, The University of British Columbia, Vancouver, British Columbia,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2543-3526","authenticated-orcid":true,"given":"Saud","family":"Alobaida","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King Faisal Specialist Hospital &amp; Research Centre, Riyadh,Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1984-7960","authenticated-orcid":true,"given":"Kin F.","family":"Leong","sequence":"additional","affiliation":[{"name":"Pediatric Institute, Kuala Lumpur General Hospital, Kuala Lumpur,Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1579-3624","authenticated-orcid":true,"given":"Alex H.C.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, The University of Calgary, Calgary, Alberta,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11926-011-0167-9","volume":"13","author":"Batthish M.","year":"2011","unstructured":"Batthish M.; Feldman B.M.; Juvenile dermatomyositis. Curr Rheumatol Rep 2011,13(3),216-224","journal-title":"Curr Rheumatol Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/acr.22142","volume":"66","author":"Robinson A.B.","year":"2014","unstructured":"Robinson A.B.; Hoeltzel M.F.; Wahezi D.M.; Becker M.L.; Kessler E.A.; Schmeling H.; Carrasco R.; Huber A.M.; Feldman B.M.; Reed A.M.; Clinical characteristics of children with juvenile dermatomyositis: the childhood arthritis and rheumatology research alliance registry. Arthritis Care Res (Hoboken) 2014,66(3),404-410","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.14740\/jocmr3547w","volume":"10","author":"Antoine M.","year":"2018","unstructured":"Antoine M.; Reeves P.T.; Rohena L.; Jones O.; Faux B.; Fashionably late: A case of delayed cutaneous manifestations in juvenile dermatomyositis. J Clin Med Res 2018,10(11),848-852","journal-title":"J Clin Med Res"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D32W9993P3","volume":"15","author":"Schmieder A.","year":"2009","unstructured":"Schmieder A.; von Komorowski G.; Peitsch W.K.; Goerdt S.; Goebeler M.; Juvenile dermatomyositis in an 8-year-old boy. Dermatol Online J 2009,15(6),3","journal-title":"Dermatol Online J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12969-018-0257-6","volume":"16","author":"Hinze C.H.","year":"2018","unstructured":"Hinze C.H.; Oommen P.T.; Dressler F.; Urban A.; Weller-Heinemann F.; Speth F.; Lainka E.; Brunner J.; Fesq H.; Foell D.; M&#xFC;ller-Felber W.; Neudorf U.; Rietschel C.; Schwarz T.; Schara U.; Haas J.P.; Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria. Pediatr Rheumatol Online J 2018,16(1),40","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pcl.2018.04.006","volume":"65","author":"Huber A.M.","year":"2018","unstructured":"Huber A.M.; Juvenile idiopathic inflammatory myopathies. Pediatr Clin North Am 2018,65(4),739-756","journal-title":"Pediatr Clin North Am"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.berh.2017.12.003","volume":"31","author":"Wu Q.","year":"2017","unstructured":"Wu Q.; Wedderburn L.R.; McCann L.J.; Juvenile dermatomyositis: latest advances. Best Pract Res Clin Rheumatol 2017,31(4),535-557","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/IJPM.IJPM_387_17","volume":"62","author":"Challa S.","year":"2019","unstructured":"Challa S.; Hui M.; Jakati S.; Uppin M.S.; Rajasekhar L.; Kannan M.A.; Lingappa L.; Jagarlapudi M.M.K.; Juvenile idiopathic inflammatory myopathies: A clinicopathological study with emphasis on muscle histology. Indian J Pathol Microbiol 2019,62(1),61-66","journal-title":"Indian J Pathol Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00296-018-4229-4","volume":"39","author":"Mantoo M.R.","year":"2019","unstructured":"Mantoo M.R.; Tripathy S.K.; Phulware R.H.; Bagri N.K.; Hari P.; Barwad A.; Juvenile dermatomyositis with IgA nephropathy: case-based review. Rheumatol Int 2019,39(3),577-581","journal-title":"Rheumatol Int"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"McCann  LJ","year":"2006","unstructured":"McCann LJ; Juggins AD.; Maillard SM; Wedderburn LR.; Davidson JE.; Murray KJ.; The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) -- clinical characteristics of children recruited within the first 5 yr. Rheumatology 2006,45(10),1255-1260","journal-title":"Rheumatology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40272-017-0240-6","volume":"19","author":"Papadopoulou C.","year":"2017","unstructured":"Papadopoulou C.; Wedderburn L.R.; Treatment of Juvenile Dermatomyositis: An Update. Paediatr Drugs 2017,19(5),423-434","journal-title":"Paediatr Drugs"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fped.2018.00284","volume":"6","author":"Papadopoulou C.","year":"2018","unstructured":"Papadopoulou C.; McCann L.J.; The Vasculopathy of Juvenile Dermatomyositis. Front Pediatr 2018,6,284","journal-title":"Front Pediatr"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","volume":"28","author":"Ramanan A.V.","year":"2002","unstructured":"Ramanan A.V.; Feldman B.M.; Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002,28(4),833-857","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1055\/s-0040-1705120","volume":"40","author":"Swafford C.","year":"2020","unstructured":"Swafford C.; Roach E.S.; Juvenile dermatomyositis and the inflammatory myopathies. Semin Neurol 2020,40(3),342-348","journal-title":"Semin Neurol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1097\/BPO.0000000000000358","volume":"35","author":"Welborn M.C.","year":"2015","unstructured":"Welborn M.C.; Gottschalk H.; Bindra R.; Juvenile dermatomyositis: a case of calcinosis cutis of the elbow and review of the literature. J Pediatr Orthop 2015,35(5),e43-e46","journal-title":"J Pediatr Orthop"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2165\/11310550-000000000-00000","volume":"11","author":"Huber A.M.","year":"2009","unstructured":"Huber A.M.; Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment. Paediatr Drugs 2009,11(6),361-374","journal-title":"Paediatr Drugs"},{"key":"ref=17","first-page":"256","volume":"15","author":"Leung A.K.C.","year":"2016","unstructured":"Leung A.K.C.; Barankin B.; Hon K.L.; What is causing this muscle weakness and rash? Consultant for Pediatricians 2016,15,256-259","journal-title":"Consultant for Pediatricians"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12519-019-00313-8","volume":"16","author":"Wu J.Q.","year":"2020","unstructured":"Wu J.Q.; Lu M.P.; Reed A.M.; Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J Pediatr 2020,16(1),31-43","journal-title":"World J Pediatr"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"318.e1","DOI":"10.1016\/j.jpeds.2015.12.077","volume":"171","author":"Sukumaran S.","year":"2016","unstructured":"Sukumaran S.; Palmer T.; Vijayan V.; Heliotrope rash and gottron papules in a child with juvenile dermatomyositis. J Pediatr 2016,171,318.e1","journal-title":"J Pediatr"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/art.21068","volume":"53","author":"Pachman L.M.","year":"2005","unstructured":"Pachman L.M.; Lipton R.; Ramsey-Goldman R.; Shamiyeh E.; Abbott K.; Mendez E.P.; Dyer A.; Curdy D.M.; Vogler L.; Reed A.; Cawkwell G.; Zemel L.; Sandborg C.; Rivas-Chacon R.; Hom C.; Ilowite N.; Gedalia A.; Gitlin J.; Borzy M.; History of infection before the onset of juvenile dermatomyositis: results from the national institute of arthritis and musculoskeletal and skin diseases research registry. Arthritis Rheum 2005,53(2),166-172","journal-title":"Arthritis Rheum"},{"key":"ref=21","author":"Gara S.","year":"2020","unstructured":"Gara S.; Jamil R.T.; Muse M.E.; Litaiem N.; Juvenile dermatomyositis. StatPearls 2020","journal-title":"StatPearls"},{"key":"ref=22","author":"Hutchinson C.","unstructured":"Hutchinson C.; Feldman B.M.;  UpToDate","journal-title":"UpToDate"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"Mendez E.P.","year":"2003","unstructured":"Mendez E.P.; Lipton R.; Ramsey-Goldman R.; Roettcher P.; Bowyer S.; Dyer A.; Pachman L.M.; US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003,49(3),300-305","journal-title":"Arthritis Rheum"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","volume":"34","author":"Symmons DP.","year":"1995","unstructured":"Symmons DP.; Sills JA.; Davis SM.; The incidence of juvenile dermatomyositis: results from a nation-wide study.  Br J Rheumatol 1995,34(8),732-736","journal-title":"Br J Rheumatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1440-0960.1996.tb01018.x","volume":"37","author":"Halbert A.R.","year":"1996","unstructured":"Halbert A.R.; Juvenile dermatomyositis. Australas J Dermatol 1996,37(2),106-108","journal-title":"Australas J Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","volume":"23","author":"Wedderburn L.R.","year":"2009","unstructured":"Wedderburn L.R.; Rider L.G.; Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol 2009,23(5),665-678","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/1744666X.2018.1535901","volume":"14","author":"Huber A.M.","year":"2018","unstructured":"Huber A.M.; Update on the clinical management of juvenile dermatomyositis. Expert Rev Clin Immunol 2018,14(12),1021-1028","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/rheumatology\/kex468","volume":"57","author":"Karasawa R.","year":"2018","unstructured":"Karasawa R.; Tamaki M.; Sato T.; Tanaka M.; Nawa M.; Yudoh K.; Jarvis J.N.; Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics. Rheumatology (Oxford) 2018,57(4),671-676","journal-title":"Rheumatology (Oxford)"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jmii.2014.05.012","volume":"49","author":"Yu H.H.","year":"2016","unstructured":"Yu H.H.; Chang H.M.; Chiu C.J.; Yang Y.H.; Lee J.H.; Wang L.C.; Lin Y.T.; Chiang B.L.; Detection of anti-p155\/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis. J Microbiol Immunol Infect 2016,49(2),264-270","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/art.40800","volume":"71","author":"Moneta G.M.","year":"2019","unstructured":"Moneta G.M.; Pires Marafon D.; Marasco E.; Rosina S.; Verardo M.; Fiorillo C.; Minetti C.; Bracci-Laudiero L.; Ravelli A.; De Benedetti F.; Nicolai R.; Muscle expression of type I and type II intewrferons is increased in juvenile dermatomyositis and related to clinical and histologic features. Arthritis Rheumatol 2019,71(6),1011-1021","journal-title":"Arthritis Rheumatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","volume":"195","author":"Pachman L.M.","year":"2018","unstructured":"Pachman L.M.; Khojah A.M.; Advances in juvenile dermatomyositis: myositis specific antibodies aid in understanding disease heterogeneity. J Pediatr 2018,195,16-27","journal-title":"J Pediatr"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"7814287","DOI":"10.1155\/2019\/7814287","volume":"2019","author":"Qiu C.C.","year":"2019","unstructured":"Qiu C.C.; Su Q.S.; Zhu S.Y.; Liu R.C.; Identification of potential biomarkers and biological pathways in juvenile dermatomyositis based on miRNA-mRNA network. BioMed Res Int 2019,2019,7814287","journal-title":"BioMed Res Int"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1752-1947-8-54","volume":"8","author":"McCrea N.","year":"2014","unstructured":"McCrea N.; Al-Sabbagh A.; Ahmed S.; Walker D.; Rangaraj S.; Onset of juvenile dermatomyositis following varicella infection in a 12-month-old child: a case report. J Med Case Reports 2014,8,54","journal-title":"J Med Case Reports"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00314-7","author":"Zheng Q.","year":"2019","unstructured":"Zheng Q.; Zhu K.; Gao C.N.; Xu Y.P.; Lu M.P.; Prevalence of Epstein-Barr virus infection and characteristics of lymphocyte subsets in newly onset juvenile dermatomyositis. World J Pediatr 2019","journal-title":"World J Pediatr"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12519-019-00314-7","volume":"12","author":"Adams C","year":"1995","unstructured":"Adams C; August CS; Maguire H; Sladky JT; Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995,12(1),58-61","journal-title":"Pediatr Neurol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-4615-4857-7_27","volume":"455","author":"Dourmishev A.L.","year":"1999","unstructured":"Dourmishev A.L.; Dourmishev L.A.; Dermatomyositis and drugs. Adv Exp Med Biol 1999,455,187-191","journal-title":"Adv Exp Med Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/acr.23840","volume":"71","author":"Neely J.","year":"2019","unstructured":"Neely J.; Long C.S.; Sturrock H.; Kim S.; Association of short-term ultraviolet radiation exposure and disease severity in juvenile dermatomyositis: results from the childhood arthritis and rheumatology research alliance legacy registry. Arthritis Care Res (Hoboken) 2019,71(12),1600-1605","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/acr.22358","volume":"66","author":"Orione M.A.","year":"2014","unstructured":"Orione M.A.; Silva C.A.; Sallum A.M.; Campos L.M.; Omori C.H.; Braga A.L.; Farhat S.C.; Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy. Arthritis Care Res (Hoboken) 2014,66(10),1571-1575","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/berh.1999.0076","volume":"14","author":"Rider L.G.","year":"2000","unstructured":"Rider L.G.; Miller F.W.;  Best Pract Res Clin Rheumatol 2000,14(1),37-54","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1542\/peds.2010-3022","volume":"127","author":"Niewold  TB","year":"2011","unstructured":"Niewold TB; Wu SC; Smith M; Morgan GA; Pachman LM; Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 2011,127(5),e1239-1246","journal-title":"Pediatrics"},{"key":"ref=41","author":"Hutchinson C.","unstructured":"Hutchinson C.; Feldman B.M.;  UpToDate","journal-title":"UpToDate"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1111\/pde.12540","volume":"32","author":"Smith V.M.","year":"2015","unstructured":"Smith V.M.; Leone V.; Clark S.; Palmoplantar hyperkeratosis: a rare cutaneous manifestation of juvenile dermatomyositis. Pediatr Dermatol 2015,32(3),e106-e107","journal-title":"Pediatr Dermatol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14397595.2020.1718866","volume":"30","author":"Kobayashi I.","year":"2020","unstructured":"Kobayashi I.; Akioka S.; Kobayashi N.; Iwata N.; Takezaki S.; Nakaseko H.; Sato S.; Nishida Y.; Nozawa T.; Yamasaki Y.; Yamazaki K.; Arai S.; Nishino I.; Mori M.; Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update. Mod Rheumatol 2020,30(3),411-423","journal-title":"Mod Rheumatol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"979856","DOI":"10.1155\/2014\/979856","volume":"2014","author":"Al-Janobi G.","year":"2014","unstructured":"Al-Janobi G.; Alkhalidi H.; Omair M.A.; Unilateral heliotrope rash in juvenile dermatomyositis: an unusual presentation of an underlying serious disease. Case Rep Rheumatol 2014,2014,979856","journal-title":"Case Rep Rheumatol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/RHU.0000000000000890","volume":"26","author":"Shimizu M.","year":"2020","unstructured":"Shimizu M.; Inoue N.; Mizuta M.; Sakakibara Y.; Hamaguchi Y.; Yachie A.; Periorbital Edema as the Initial Sign of Juvenile Dermatomyositis. J Clin Rheumatol 2020,26(3),e61","journal-title":"J Clin Rheumatol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12098-016-2263-3","volume":"84","author":"Kumar A.","year":"2017","unstructured":"Kumar A.; Gupta A.; Suri D.; Gupta A.; Singh S.; The expanding spectrum of gottron papules in juvenile dermatomyositis. Indian J Pediatr 2017,84(3),242-243","journal-title":"Indian J Pediatr"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00296-018-4038-9","volume":"38","author":"Jindal A.K.","year":"2018","unstructured":"Jindal A.K.; Guleria S.; Pilania R.K.; Bishnoi A.; Vinay K.; Dogra S.; Suri D.; Rawat A.; Singh S.; Inverse Gottron papules in juvenile dermatomyositis: an under recognized clinical entity. Rheumatol Int 2018,38(6),1153-1160","journal-title":"Rheumatol Int"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1525-1470.2011.01585.x","volume":"29","author":"Quinter S.D.","year":"2012","unstructured":"Quinter S.D.; Chiu Y.E.; Lyon V.B.; Holland K.E.; Ruggeri S.Y.; Drolet B.A.; Inverse Gottron\u2019s papules: an unusual cutaneous manifestation of juvenile dermatomyositis. Pediatr Dermatol 2012,29(5),641-644","journal-title":"Pediatr Dermatol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/BOR.0b013e328331927e","volume":"21","author":"Lowry C.A.","year":"2009","unstructured":"Lowry C.A.; Pilkington C.A.; Juvenile dermatomyositis: extramuscular manifestations and their management. Curr Opin Rheumatol 2009,21(6),575-580","journal-title":"Curr Opin Rheumatol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/rheumatology\/kew330","volume":"56","author":"Razmi T.M.","year":"2017","unstructured":"Razmi T.M.; Vinay K.; Parsad D.;  Rheumatology (Oxford) 2017,56(2),254","journal-title":"Rheumatology (Oxford)"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/jpc.1_14739","volume":"56","author":"Amoroso S.","year":"2020","unstructured":"Amoroso S.; Pastore S.; Tommasini A.; Taddio A.; Palmar erythema: A diagnostic clue of juvenile dermatomyositis. J Paediatr Child Health 2020,56(7),1159","journal-title":"J Paediatr Child Health"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab177","author":"Lu J.","year":"2021","unstructured":"Lu J.; Liu C.; Zhou X.; Palmar erythema and palmar papules as predictors for dermatomyositis-related acute\/subacute interstitial lung disease: a retrospective study. Rheumatology (Oxford) 2021","journal-title":"Rheumatology (Oxford)"},{"key":"ref=53","author":"Leung A.K.C.","unstructured":"Leung A.K.C.; Lam J.M.; Leong K.F.; Hon K.L.; Vitiligo: An updated narrative review. Curr Pediatr Rev \n(in press).","journal-title":"Curr Pediatr Rev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3899\/jrheum.170885","volume":"45","author":"Tidwell W.J.","year":"2018","unstructured":"Tidwell W.J.; Callen J.P.; Koebner Phenomenon in Juvenile Dermatomyositis. J Rheumatol 2018,45(3),437","journal-title":"J Rheumatol"},{"key":"ref=55","author":"Tsang V.","unstructured":"Tsang V.; Leung A.; Lam J.M.; Cutaneous lupus erythematosus in children. Curr Pediatr Rev \n(in press).","journal-title":"Curr Pediatr Rev"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mjd.2001.113686","volume":"45","author":"Peloro  TM.","year":"2001","unstructured":"Peloro TM.; Miller OF 3rd, Hahn TF, Newman ED. Juvenile dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol 2001,45(1),28-34","journal-title":"J Am Acad Dermatol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e3935","DOI":"10.7759\/cureus.3935","volume":"11","author":"Gupta P.","year":"2019","unstructured":"Gupta P.; Shruti S.; Chaudhary V.; Khullar G.; Siraj F.; Juvenile Dermatomyositis: A Case Report and Review of Literature. Cureus 2019,11(1),e3935","journal-title":"Cureus"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/acr.23338","volume":"70","author":"Barth Z.","year":"2018","unstructured":"Barth Z.; Witczak B.N.; Flat&#xF8; B.; Koller A.; Sjaastad I.; Sanner H.; Assessment of microvascular abnormalities by nailfold capillaroscopy in juvenile dermatomyositis after medium- to long-term followup. Arthritis Care Res (Hoboken) 2018,70(5),768-776","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/acr.23687","volume":"71","author":"Barth Z.","year":"2019","unstructured":"Barth Z.; Schwartz T.; Flat&#xF8; B.; Aal&#xF8;kken T.M.; Koller A.; Lund M.B.; Sjaastad I.; Sanner H.; Association between nailfold capillary density and pulmonary and cardiac involvement in medium to longstanding juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2019,71(4),492-497","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"102533","DOI":"10.1016\/j.autrev.2020.102533","volume":"19","author":"Chung M.P.","year":"2020","unstructured":"Chung M.P.; Richardson C.; Kirakossian D.; Orandi A.B.; Saketkoo L.A.; Rider L.G.; Schiffenbauer A.; von M&#xFC;hlen C.A.; Chung L.; Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmun Rev 2020,19(6),102533","journal-title":"Autoimmun Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1056\/NEJMicm1809669","volume":"381","author":"Li J.","year":"2019","unstructured":"Li J.; Zhou Z.; Calcinosis in juvenile dermatomyositis. N Engl J Med 2019,381(16),e31","journal-title":"N Engl J Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12969-018-0299-9","volume":"16","author":"Orandi A.B.","year":"2018","unstructured":"Orandi A.B.; Dharnidharka V.R.; Al-Hammadi N.; Baszis K.W.; Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatr Rheumatol Online J 2018,16(1),84","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1186\/s12969-018-0299-9","volume":"43","author":"Pachman  LM.","year":"2000","unstructured":"Pachman LM.; Liotta-Davis MR; Hong DK; Kinsella TR; Mendez EP; Kinder JM; TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 2000,43(10),2368-2377","journal-title":"Arthritis Rheum"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1186\/s12969-018-0299-9","volume":"53","author":"Tansley  SL.","year":"2014","unstructured":"Tansley SL.; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Lucy R; Wedderburn LR; Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 2014,53(12),2204-2208","journal-title":"Rheumatology (Oxford)"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5606\/ArchRheumatol.2018.6506","volume":"33","author":"Choi Y.J.","year":"2017","unstructured":"Choi Y.J.; Yoo W.H.; Panniculitis, a rare presentation of onset and exacerbation of juvenile dermatomyositis: A case report and literature review.  Arch Rheumatol 2017,33(3),367-371","journal-title":"Arch Rheumatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/ced.12576","volume":"40","author":"Otero Rivas M.M.","year":"2015","unstructured":"Otero Rivas M.M.; Vicente Villa A.; Gonz&#xE1;lez Lara L.; Su&#xF1;ol Capella M.; Ant&#xF3;n L&#xF3;pez J.; Gonz&#xE1;lez Ense&#xF1;at M.A.; Panniculitis in juvenile dermatomyositis. Clin Exp Dermatol 2015,40(5),574-575","journal-title":"Clin Exp Dermatol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/14397595.2018.1511026","volume":"29","author":"Sakurai N.","year":"2019","unstructured":"Sakurai N.; Hino-Shishikura A.; Nozawa T.; Kamide H.; Ohara A.; Nishimura K.; Kikuchi M.; Hara R.; Mori M.; Ito S.; Clinical significance of subcutaneous fat and fascial involvement in juvenile dermatomyositis. Mod Rheumatol 2019,29(5),808-813","journal-title":"Mod Rheumatol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/j.reuma.2017.06.006","volume":"15","author":"Torres Jim&#xE9;nez A.R.","year":"2019","unstructured":"Torres Jim&#xE9;nez A.R.; Sol&#xED;s-Vallejo E.; C&#xE9;spedes-Cruz A.I.; S&#xE1;nchez-Uribe M.; Subcutaneous edema in juvenile dermatomyositis. Reumatol Clin 2019,15(5),e49-e50","journal-title":"Reumatol Clin"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"bcr2017222915","DOI":"10.1136\/bcr-2017-222915","volume":"2018","author":"Gupta A.","year":"2018","unstructured":"Gupta A.; Pilania R.K.; Prasad V.D.; Guleria S.; Extensive skin ulcers in a child with juvenile dermatomyositis. BMJ Case Rep 2018,2018,bcr2017222915","journal-title":"BMJ Case Rep"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pedneo.2016.07.001","volume":"58","author":"Wakiguchi H.","year":"2017","unstructured":"Wakiguchi H.; Takei S.; Kawano Y.; Axillary skin ulcers in infants with juvenile dermatomyositis. Pediatr Neonatol 2017,58(3),287-288","journal-title":"Pediatr Neonatol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1097\/RHU.0000000000000757","volume":"26","author":"Jindal A.K.","year":"2020","unstructured":"Jindal A.K.; Sharma A.; Rawat A.; Scrotal and penile ulcer in juvenile dermatomyositis: an unusual occurrence. J Clin Rheumatol 2020,26(1),e7-e8","journal-title":"J Clin Rheumatol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.arcped.2018.12.002","volume":"26","author":"Bader-Meunier B.","year":"2019","unstructured":"Bader-Meunier B.; Gitiaux C.; Belot A.; Brochard K.; Mouy R.; Ponce D.; Bughin V.; Jouen F.; Musset L.; Allenbach Y.; Hachulla E.; Maillard H.; Meyer A.; Bourrat E.; Benveniste O.; French expert opinion for the management of juvenile dermatomyositis. Arch Pediatr 2019,26(2),120-125","journal-title":"Arch Pediatr"},{"key":"ref=73","first-page":"1106","volume":"28","author":"Huber A.M.","year":"2001","unstructured":"Huber A.M.; Hicks J.E.; Lachenbruch P.A.; Perez M.D.; Zemel L.S.; Rennebohm R.M.; Wallace C.A.; Lindsley C.B.; Passo M.H.; Ballinger S.H.; Bowyer S.L.; Reed A.M.; White P.H.; Katona I.M.; Miller F.W.; Rider L.G.; Feldman B.M.; Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies. J Rheumatol 2001,28(5),1106-1111","journal-title":"J Rheumatol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.20179","volume":"50","author":"Huber A.M.","year":"2004","unstructured":"Huber A.M.; Feldman B.M.; Rennebohm R.M.; Hicks J.E.; Lindsley C.B.; Perez M.D.; Zemel L.S.; Wallace C.A.; Ballinger S.H.; Passo M.H.; Reed A.M.; Summers R.M.; White P.H.; Katona I.M.; Miller F.W.; Lachenbruch P.A.; Rider L.G.; Validation and clinical significance of the childhood myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004,50(5),1595-1603","journal-title":"Arthritis Rheum"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"Rider L.G.","year":"2010","unstructured":"Rider L.G.; Koziol D.; Giannini E.H.; Jain M.S.; Smith M.R.; Whitney-Mahoney K.; Feldman B.M.; Wright S.J.; Lindsley C.B.; Pachman L.M.; Villalba M.L.; Lovell D.J.; Bowyer S.L.; Plotz P.H.; Miller F.W.; Hicks J.E.; Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2010,62(4),465-472","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/rheumatology\/key421","volume":"58","author":"Rosina S.","year":"2019","unstructured":"Rosina S.; Consolaro A.; van Dijkhuizen P.; Pistorio A.; Varnier G.C.; Bovis F.; Nistala K.; Maillard S.; Civino A.; Tsitsami E.; de Inocencio J.; Jelusic M.; Vojinovic J.; Espada G.; Makay B.; Katsicas M.M.; Pratsidou-Gertsi P.; Lazarevic D.; Rao A.P.; Pires Marafon D.; Martini A.; Pilkington C.; Ruperto N.; Ravelli A.; Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. Rheumatology (Oxford) 2019,58(7),1196-1205","journal-title":"Rheumatology (Oxford)"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/acr.23491","volume":"70","author":"Varnier G.C.","year":"2018","unstructured":"Varnier G.C.; Rosina S.; Ferrari C.; Pistorio A.; Consolaro A.; Bovis F.; Dalpr&#xE0; S.; Pilkington C.; Maillard S.; Civino A.; Tsitsami E.; de Inocencio J.; Jelusic M.; Vojinovic J.; Espada G.; Makay B.; Katsicas M.M.; Pratsidou-Gertsi P.; Lazarevic D.; Rao A.P.; Marafon D.P.; Ruperto N.; Martini A.; Ravelli A.; Development and testing of a hybrid measure of muscle strength in juvenile dermatomyositis for use in routine care. Arthritis Care Res (Hoboken) 2018,70(9),1312-1319","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3389\/fimmu.2018.02951","volume":"9","author":"Wienke J.","year":"2018","unstructured":"Wienke J.; Deakin C.T.; Wedderburn L.R.; van Wijk F.; van Royen-Kerkhof A.; Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools. Front Immunol 2018,9,2951","journal-title":"Front Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"Bellutti Enders F.","year":"2017","unstructured":"Bellutti Enders F.; Bader-Meunier B.; Baildam E.; Constantin T.; Dolezalova P.; Feldman B.M.; Lahdenne P.; Magnusson B.; Nistala K.; Ozen S.; Pilkington C.; Ravelli A.; Russo R.; Uziel Y.; van Brussel M.; van der Net J.; Vastert S.; Wedderburn L.R.; Wulffraat N.; McCann L.J.; van Royen-Kerkhof A.; Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis 2017,76(2),329-340","journal-title":"Ann Rheum Dis"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"Lazarevic D.","year":"2013","unstructured":"Lazarevic D.; Pistorio A.; Palmisani E; Miettunen P; Ravelli A; Pilkington C; The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 2013,72(5),686-693","journal-title":"Ann Rheum Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11926-019-0871-4","volume":"21","author":"Li D.","year":"2019","unstructured":"Li D.; Tansley S.L.; Juvenile dermatomyositis-clinical phenotypes. Curr Rheumatol Rep 2019,21(12),74","journal-title":"Curr Rheumatol Rep"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1093\/rheumatology\/key190","volume":"57","author":"Mamyrova G.","year":"2018","unstructured":"Mamyrova G.; Kishi T.; Targoff I.N.; Ehrlich A.; Curiel R.V.; Rider L.G.; Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford) 2018,57(11),1956-1963","journal-title":"Rheumatology (Oxford)"},{"key":"ref=83","first-page":"171","volume":"14","author":"Nilipour Y.","year":"2015","unstructured":"Nilipour Y.; Ghiasi M.; Rohani M.; Omrani F.; Juvenile dermatomyositis without skin lesions. Iran J Neurol 2015,14(3),171-173","journal-title":"Iran J Neurol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamaneurol.2020.0673","volume":"77","author":"Inoue M.","year":"2020","unstructured":"Inoue M.; Tanboon J.; Hirakawa S.; Komaki H.; Fukushima T.; Awano H.; Tajima T.; Yamazaki K.; Hayashi R.; Mori T.; Shibuya K.; Yamanoi T.; Yoshimura H.; Ogawa T.; Katayama A.; Sugai F.; Nakayama Y.; Yamaguchi S.; Hayashi S.; Noguchi S.; Tachimori H.; Okiyama N.; Fujimoto M.; Nishino I.; Association of dermatomyositis sine dermatitis with anti-nuclear matrix protein 2 autoantibodies. JAMA Neurol 2020,77(7),872-877","journal-title":"JAMA Neurol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MPG.0000000000002575","volume":"70","author":"Besnard C.","year":"2020","unstructured":"Besnard C.; Gitiaux C.; Girard M.; Galmiche-Rolland L.; Talbotec C.; Quartier P.; Bodemer C.; Berteloot L.; Bader-Meunier B.; Severe abdominal manifestations in juvenile dermatomyositis. J Pediatr Gastroenterol Nutr 2020,70(2),247-251","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3899\/jrheum.190929","volume":"47","author":"Cannon L.","year":"2020","unstructured":"Cannon L.; Dvergsten J.; Stingl C.; Juvenile dermatomyositis and development of malignancy: 2 case reports and a literature review. J Rheumatol 2020,47(3),479","journal-title":"J Rheumatol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12969-017-0182-0","volume":"15","author":"Cantez S.","year":"2017","unstructured":"Cantez S.; Gross G.J.; MacLusky I.; Feldman B.M.; Cardiac findings in children with juvenile dermatomyositis at disease presentation. Pediatr Rheumatol Online J 2017,15(1),54","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/09273948.2017.1305421","volume":"26","author":"Choi R.Y.","year":"2018","unstructured":"Choi R.Y.; Swan R.J.; Hersh A.; Vitale A.T.; Retinal manifestations of juvenile dermatomyositis: Case report of bilateral diffuse chorioretinopathy with paracentral acute middle maculopathy and review of the literature. Ocul Immunol Inflamm 2018,26(6),929-933","journal-title":"Ocul Immunol Inflamm"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1111\/j.1756-185X.2011.01603.x","volume":"15","author":"Dogra S.","year":"2012","unstructured":"Dogra S.; Suri D.; Shah R.; Rawat A.; Singh S.; Sodhi K.S.; Spontaneous pneumomediastinum: a rare complication of juvenile dermatomyositis. Int J Rheum Dis 2012,15(5),e131-e133","journal-title":"Int J Rheum Dis"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/20469047.2020.1765123","volume":"40","author":"Ghosh R.","year":"2020","unstructured":"Ghosh R.; Roy D.; Dubey S.; Abdelrahman K.; Dey A.K.; Chatterjee S.; Lahiri D.; Ray B.K.; Juvenile dermatomyositis presenting as complete heart block in a 10-year-old girl. Paediatr Int Child Health [Online ahead of print.].2020,40(4),251-254","journal-title":"Paediatr Int Child Health"},{"key":"ref=91","author":"Hutchinson C.","unstructured":"Hutchinson C.; Feldman B.M.;  UpToDate","journal-title":"UpToDate"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neurol.2018.10.010","volume":"175","author":"Khattab H.","year":"2019","unstructured":"Khattab H.; Rafai M.A.; El Moutawakil B.; El Otmani H.; Mikou N.; Bouayed K.; Associated pediatric neuromyelitis optica and dermatomyositis: A case report. Rev Neurol (Paris) 2019,175(7-8),489-492","journal-title":"Rev Neurol (Paris)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1111\/1346-8138.14852","volume":"46","author":"Koike M.","year":"2019","unstructured":"Koike M.; Hayashi S.; Okamoto M.; Kaminaga T.; Hamasaki Y.; Igawa K.; Juvenile dermatomyositis associated with anti-melanoma differentiation-associated gene 5 antibody positivity without complications of interstitial lung disease during the clinical course: A case report. J Dermatol 2019,46(9),e308-e309","journal-title":"J Dermatol"},{"key":"ref=94","first-page":"638","volume":"31","author":"Kozu K.T.","year":"2013","unstructured":"Kozu K.T.; Silva C.A.; Bonf&#xE1; E.; Sallum A.M.; Pereira R.M.; Viana V.S.; Borba E.; Campos L.M.; Dyslipidaemia in juvenile dermatomyositis: the role of disease activity. Clin Exp Rheumatol 2013,31(4),638-644","journal-title":"Clin Exp Rheumatol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/rheumatology\/kex262","volume":"56","author":"Meneghel A.","year":"2017","unstructured":"Meneghel A.; Martini G.; Birolo C.; Tosoni A.; Pettenazzo A.; Zulian F.; Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis. Rheumatology (Oxford) 2017,56(10),1822-1823","journal-title":"Rheumatology (Oxford)"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/acr.24065","volume":"72","author":"Nordal E.","year":"2020","unstructured":"Nordal E.; Pistorio A.; Rygg M.; Giancane G.; Maghnie M.; Di Iorgi N.; Flemming K.; Hofer M.; Melo-Gomes J.A.; Bica B.E.R.G.; Brunner J.; Dannecker G.; Gerloni V.; Harjacek M.; Huppertz H.I.; Pratsidou-Gertsi P.; Nielsen S.; Stanevicha V.; Ten Cate R.; Vougiouka O.; Pastore S.; Simonini G.; Ravelli A.; Martini A.; Ruperto N.; Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study. Arthritis Care Res (Hoboken) 2020,72(2),265-273","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/ppul.22742","volume":"48","author":"Pouessel G.","year":"2013","unstructured":"Pouessel G.; Deschildre A.; Le Bourgeois M.; Cuisset J.M.; Catteau B.; Karila C.; N&#xE8;ve V.; Thumerelle C.; Quartier P.; Tillie-Leblond I.; The lung is involved in juvenile dermatomyositis. Pediatr Pulmonol 2013,48(10),1016-1025","journal-title":"Pediatr Pulmonol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.nmd.2018.06.011","volume":"28","author":"Rego de Figueiredo I.","year":"2018","unstructured":"Rego de Figueiredo I.; Guerreiro Castro S.; Bernardino V.; Silva Nunes J.; Alves P.; Moraes-Fontes M.F.; Juvenile dermatomyositis forty years on: Case report. Neuromuscul Disord 2018,28(9),791-797","journal-title":"Neuromuscul Disord"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00403-019-01913-0","volume":"311","author":"Ren Z.","year":"2019","unstructured":"Ren Z.; Laumann A.E.; Silverberg J.I.; Association of dermatomyositis with systemic and opportunistic infections in the United States. Arch Dermatol Res 2019,311(5),377-387","journal-title":"Arch Dermatol Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"bcr2014205066","DOI":"10.1136\/bcr-2014-205066","volume":"2014","author":"Sanches B.F.","year":"2014","unstructured":"Sanches B.F.; Martins T.; Santos M.J.; Azeredo P.; Acute acalculous cholecystitis in a patient with juvenile dermatomyositis. BMJ Case Rep 2014,2014,bcr2014205066","journal-title":"BMJ Case Rep"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/rheumatology\/kex465","volume":"57","author":"Silverberg J.I.","year":"2018","unstructured":"Silverberg J.I.; Kwa L.; Kwa M.C.; Laumann A.E.; Ardalan K.; Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample. Rheumatology (Oxford) 2018,57(4),694-702","journal-title":"Rheumatology (Oxford)"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2017.03.033","volume":"377","author":"St&#xFC;bgen J.P.","year":"2017","unstructured":"St&#xFC;bgen J.P.; Juvenile dermatomyositis\/polymyositis and lymphoma. J Neurol Sci 2017,377,19-24","journal-title":"J Neurol Sci"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D32110028957","volume":"21","author":"Turan E.","year":"2015","unstructured":"Turan E.; Yesilova Y.; Surucu H.A.; Tanrikulu O.; Eroglu N.; Kocarslan S.; Juvenile dermatomyositis with joint contractures and calcinosis cutis. Dermatol Online J 2015,21(10),15","journal-title":"Dermatol Online J"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14397595.2018.1452353","volume":"29","author":"Ueki M","year":"2019","unstructured":"Ueki M; Kobayashi I; Shunichiro Takezaki S; Tozawa Y; Okura Y; Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Mod Rheumatol 2019,29(2),351-356","journal-title":"Mod Rheumatol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42358-018-0024-x","volume":"58","author":"Kozu K.T.","year":"2018","unstructured":"Kozu K.T.; Silva C.A.; Aikawa N.E.; Pereira R.M.R.; Sallum A.M.; Savioli C.; Borba E.; Campos L.M.; Juvenile dermatomyositis: is periodontal disease associated with dyslipidemia? Adv Rheumatol 2018,58(1),28","journal-title":"Adv Rheumatol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10067-017-3901-5","volume":"37","author":"Challa D.","year":"2018","unstructured":"Challa D.; Crowson C.S.; Niewold T.B.; Reed A.M.; Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the childhood arthritis and rheumatology research alliance (CARRA) legacy registry. Clin Rheumatol 2018,37(4),1011-1015","journal-title":"Clin Rheumatol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12969-018-0286-1","volume":"16","author":"Kwa M.C.","year":"2018","unstructured":"Kwa M.C.; Silverberg J.I.; Ardalan K.; Inpatient burden of juvenile dermatomyositis among children in the United States. Pediatr Rheumatol Online J 2018,16(1),70","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1742395317690034","volume":"13","author":"Kountz-Edwards S.","year":"2017","unstructured":"Kountz-Edwards S.; Aoki C.; Gannon C.; Gomez R.; Cordova M.; Packman W.; The family impact of caring for a child with juvenile dermatomyositis. Chronic Illn 2017,13(4),262-274","journal-title":"Chronic Illn"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpeds.2017.01.046","volume":"184","author":"Phillippi K.","year":"2017","unstructured":"Phillippi K.; Hoeltzel M.; Byun Robinson A.; Kim S.; Race, income, and disease outcomes in juvenile dermatomyositis. J Pediatr 2017,184,38-44.e1","journal-title":"J Pediatr"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-019-0332-7","volume":"17","author":"Livermore P.","year":"2019","unstructured":"Livermore P.; Gray S.; Mulligan K.; Stinson J.N.; Wedderburn L.R.; Gibson F.; Being on the juvenile dermatomyositis rollercoaster: a qualitative study. Pediatr Rheumatol Online J 2019,17(1),30","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=111","first-page":"1198","volume":"25","author":"Pachman L.M.","year":"1998","unstructured":"Pachman L.M.; Hayford J.R.; Chung A.; Daugherty C.A.; Pallansch M.A.; Fink C.W.; Gewanter H.L.; Jerath R.; Lang B.A.; Sinacore J.; Szer I.S.; Dyer A.R.; Hochberg M.C.; Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998,25(6),1198-1204","journal-title":"J Rheumatol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12969-018-0256-7","volume":"16","author":"Hinze C.H.","year":"2018","unstructured":"Hinze C.H.; Speth F.; Oommen P.T.; Haas J.P.; Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists. Pediatr Rheumatol Online J 2018,16(1),38","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2018.03.016","volume":"48","author":"Kishi T.","year":"2018","unstructured":"Kishi T.; Bayat N.; Ward M.M.; Huber A.M.; Wu L.; Mamyrova G.; Targoff I.N.; Warren-Hicks W.J.; Miller F.W.; Rider L.G.; Medications received by patients with juvenile dermatomyositis. Semin Arthritis Rheum 2018,48(3),513-522","journal-title":"Semin Arthritis Rheum"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/BOR.0000000000000538","volume":"30","author":"Varnier G.C.","year":"2018","unstructured":"Varnier G.C.; Pilkington C.A.; Wedderburn L.R.; Juvenile dermatomyositis: novel treatment approaches and outcomes. Curr Opin Rheumatol 2018,30(6),650-654","journal-title":"Curr Opin Rheumatol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"20180715","DOI":"10.1259\/bjr.20180715","volume":"92","author":"Ran J.","year":"2019","unstructured":"Ran J.; Ji S.; Morelli J.N.; Wu G.; Li X.M.; The diagnostic value of T maps and rs-EPI DWI in dermatomyositis. Br J Radiol 2019,92(1094),20180715","journal-title":"Br J Radiol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12969-017-0154-4","volume":"15","author":"Abdul-Aziz R.","year":"2017","unstructured":"Abdul-Aziz R.; Yu C.Y.; Adler B.; Bout-Tabaku S.; Lintner K.E.; Moore-Clingenpeel M.; Spencer C.H.; Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM). Pediatr Rheumatol Online J 2017,15(1),25","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/13543784.2018.1494723","volume":"27","author":"Hon K.L.","year":"2018","unstructured":"Hon K.L.; Leung A.K.C.; Leung T.N.H.; Lee V.W.Y.; Investigational drugs for atopic dermatitis. Expert Opin Investig Drugs 2018,27(8),637-647","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/17460441.2020.1722639","volume":"15","author":"Hon K.L.","year":"2020","unstructured":"Hon K.L.; Loo S.; Leung A.K.C.; Li J.T.S.; Lee V.W.Y.; An overview of drug discovery efforts for eczema: why is this itch so difficult to scratch? Expert Opin Drug Discov 2020,15(4),487-498","journal-title":"Expert Opin Drug Discov"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.yapd.2007.03.013","volume":"54","author":"Leung A.K.","year":"2007","unstructured":"Leung A.K.; Hon K.L.; Robson W.L.; Atopic dermatitis. Adv Pediatr 2007,54(1),241-273","journal-title":"Adv Pediatr"},{"key":"ref=120","first-page":"5","volume":"9:2020","author":"Leung AKC","year":"2020","unstructured":"Leung AKC; Lam JM; Leong KF; Hon KL; \nTinea corporis: an updated review. Drugs Context 2020,9:2020,5-6","journal-title":"Drugs Context"},{"key":"ref=121","doi-asserted-by":"publisher","DOI":"10.2174\/1872213X14666200810152246","author":"Leung A.K.C.","year":"2020","unstructured":"Leung A.K.C.; Lam J.M.; Leong K.F.; Leung A.A.M.; Wong A.H.C.; Hon K.L.; Nummular eczema: an updated review. Recent Pat Inflamm Allergy Drug Discov 2020","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"Bohan A.","year":"1975","unstructured":"Bohan A.; Peter J.B.; Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975,292(8),403-407","journal-title":"N Engl J Med"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","volume":"45","author":"Brown V.E.","year":"2006","unstructured":"Brown V.E.; Pilkington C.A.; Feldman B.M.; Davidson J.E.; An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford) 2006,45(8),990-993","journal-title":"Rheumatology (Oxford)"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/j.adengl.2018.05.014","volume":"109","author":"Corral-Maga&#xF1;a O.","year":"2018","unstructured":"Corral-Maga&#xF1;a O.; Bauz&#xE1;-Alonso A.F.; Escudero-G&#xF3;ngora M.M.; Lacruz L.; Mart&#xED;n-Santiago A.; Juvenile dermatomyositis: key roles of muscle magnetic resonance imaging and early aggressive treatment. Actas Dermosifiliogr 2018,109(6),e42-e46","journal-title":"Actas Dermosifiliogr"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"Lundberg I.E.","year":"2017","unstructured":"Lundberg I.E.; Tj&#xE4;rnlund A.; Bottai M.; Werth V.P.; Pilkington C.; de Visser M.; Alfredsson L.; Amato A.A.; Barohn R.J.; Liang M.H.; Singh J.A.; Aggarwal R.; Arnardottir S.; Chinoy H.; Cooper R.G.; Dank&#xF3; K.; Dimachkie M.M.; Feldman B.M.; Garcia-De La Torre I.; Gordon P.; Hayashi T.; Katz J.D.; Kohsaka H.; Lachenbruch P.A.; Lang B.A.; Li Y.; Oddis C.V.; Olesinska M.; Reed A.M.; Rutkowska-Sak L.; Sanner H.; Selva-O\u2019Callaghan A.; Song Y.W.; Vencovsky J.; Ytterberg S.R.; Miller F.W.; Rider L.G.; 2017 european league against rheumatism\/american college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 2017,69(12),2271-2282","journal-title":"Arthritis Rheumatol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"Lundberg I.E.","year":"2017","unstructured":"Lundberg I.E.; Tj&#xE4;rnlund A.; Bottai M.; Werth V.P.; Pilkington C.; Visser M.; EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 2017,76(12),1955-1964","journal-title":"Ann Rheum Dis"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12969-019-0326-5","volume":"17","author":"Giancane G.","year":"2019","unstructured":"Giancane G.; Lavarello C.; Pistorio A.; Oliveira S.K.; Zulian F.; Cuttica R.; Fischbach M.; Magnusson B.; Pastore S.; Marini R.; Martino S.; Pagnier A.; Soler C.; Sta\u0146\u0113vicha V.; Ten Cate R.; Uziel Y.; Vojinovic J.; Fueri E.; Ravelli A.; Martini A.; Ruperto N.; The PRINTO evidence-based proposal for glucocorticoids tapering\/discontinuation in new onset juvenile dermatomyositis patients. Pediatr Rheumatol Online J 2019,17(1),24","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"Ruperto N.","year":"2016","unstructured":"Ruperto N.; Pistorio A.; Oliveira S.; Zulian F.; Cuttica R.; Ravelli A.; Fischbach M.; Magnusson B.; Sterba G.; Avcin T.; Brochard K.; Corona F.; Dressler F.; Gerloni V.; Apaz M.T.; Bracaglia C.; Cespedes-Cruz A.; Cimaz R.; Couillault G.; Joos R.; Quartier P.; Russo R.; Tardieu M.; Wulffraat N.; Bica B.; Dolezalova P.; Ferriani V.; Flato B.; Bernard-Medina A.G.; Herlin T.; Trachana M.; Meini A.; Allain-Launay E.; Pilkington C.; Vargova V.; Wouters C.; Angioloni S.; Martini A.; Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet 2016,387(10019),671-678","journal-title":"Lancet"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(15)01023-5","volume":"387","author":"Miossec P.","year":"2016","unstructured":"Miossec P.; Progress in the treatment of juvenile dermatomyositis. Lancet 2016,387(10019),627-628","journal-title":"Lancet"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5152\/eurjrheum.2020.20045","volume":"7","author":"Sato R.","year":"2020","unstructured":"Sato R.; Tanaka H.; Successful low-dose cyclosporine A treatment of a case of juvenile dermatomyositis with interstitial lung disease. Eur J Rheumatol 2020,7(3),138-139","journal-title":"Eur J Rheumatol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.40418","volume":"70","author":"Deakin C.T.","year":"2018","unstructured":"Deakin C.T.; Campanilho-Marques R.; Simou S.; Moraitis E.; Wedderburn L.R.; Pullenayegum E.; Pilkington C.A.; Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginsal structural modeling. Arthritis Rheumatol 2018,70(5),785-793","journal-title":"Arthritis Rheumatol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-016-0134-0","volume":"15","author":"Kim S.","year":"2017","unstructured":"Kim S.; Kahn P.; Robinson A.B.; Lang B.; Shulman A.; Oberle E.J.; Schikler K.; Curran M.L.; Barillas-Arias L.; Spencer C.H.; Rider L.G.; Huber A.M.; Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease. Pediatr Rheumatol Online J 2017,15(1),1","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref=133","first-page":"5","volume":"9:2020","author":"Leung A.K.","year":"2020","unstructured":"Leung A.K.; McMillan T.; Human A.; Lam J.M.; Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.  Drugs Context 2020,9:2020,5-8","journal-title":"Drugs Context"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"771","DOI":"10.24953\/turkjped.2019.05.018","volume":"61","author":"&#xC7;akan M.","year":"2019","unstructured":"&#xC7;akan M.; Karada&#x11F; &#x15E;.G.; Ayaz N.A.; Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil. Turk J Pediatr 2019,61(5),771-775","journal-title":"Turk J Pediatr"},{"key":"ref=135","first-page":"1092","volume":"37","author":"Eleryan M.G.","year":"2019","unstructured":"Eleryan M.G.; Awosika O.; Akhiyat S.; Qureshi A.; Rengifo-Pardo M.; Curiel R.; Rider L.G.; Ehrlich A.; Treatment of calcinosis associated with adult and juvenile dermatomyositis using topical sodium thiosulfate via fractionated CO laser treatment. Clin Exp Rheumatol 2019,37(6),1092-1093","journal-title":"Clin Exp Rheumatol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s13312-020-1712-2","volume":"57","author":"Giri S.","year":"2020","unstructured":"Giri S.; Parida J.R.; Dash M.; Panda M.; Pamidronate in treatment of calcinosis in juvenile dermatomyositis. Indian Pediatr 2020,57(1),75-76","journal-title":"Indian Pediatr"},{"key":"ref=137","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa360","author":"S&#xF6;zeri B.","year":"2020","unstructured":"S&#xF6;zeri B.; Demir F.; A striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate. Rheumatology (Oxford) 2020","journal-title":"Rheumatology (Oxford)"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.40881","volume":"71","author":"Wienke J.","year":"2019","unstructured":"Wienke J.; Bellutti Enders F.; Lim J.; Mertens J.S.; van den Hoogen L.L.; Wijngaarde C.A.; Yeo J.G.; Meyer A.; Otten H.G.; Fritsch-Stork R.D.E.; Kamphuis S.S.M.; Hoppenreijs E.P.A.H.; Armbrust W.; van den Berg J.M.; Hissink Muller P.C.E.; Tekstra J.; Hoogendijk J.E.; Deakin C.T.; de Jager W.; van Roon J.A.G.; van der Pol W.L.; Nistala K.; Pilkington C.; de Visser M.; Arkachaisri T.; Radstake T.R.D.J.; van der Kooi A.J.; Nierkens S.; Wedderburn L.R.; van Royen-Kerkhof A.; van Wijk F.; Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation. Arthritis Rheumatol 2019,71(8),1377-1390","journal-title":"Arthritis Rheumatol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdcr.2016.10.003","volume":"3","author":"Muramatsu K.","year":"2016","unstructured":"Muramatsu K.; Ujiie H.; Yokozeki M.; Tsukinaga I.; Ito M.; Shikano T.; Suzuki A.; Tozawa Y.; Kobayashi I.; Recurrence of juvenile dermatomyositis 8years after remission. JAAD Case Rep 2016,3(1),29-32","journal-title":"JAAD Case Rep"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13075-018-1687-8","volume":"20","author":"van Dijkhuizen E.H.P.","year":"2018","unstructured":"van Dijkhuizen E.H.P.; De Iorio M.; Wedderburn L.R.; Deakin C.T.; JDRG. Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study. Arthritis Res Ther 2018,20(1),180","journal-title":"Arthritis Res Ther"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","volume":"53","author":"Sanner H.","year":"2014","unstructured":"Sanner H.; Sjaastad I.; Flat&#xF8; B.; Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool. Rheumatology (Oxford) 2014,53(9),1578-1585","journal-title":"Rheumatology (Oxford)"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/1756-185X.13759","volume":"23","author":"Sharma A.","year":"2020","unstructured":"Sharma A.; Gupta A.; Rawat A.; Suri D.; Singh S.; Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India. Int J Rheum Dis 2020,23(3),392-396","journal-title":"Int J Rheum Dis"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/art.41174","volume":"72","author":"Berntsen K.S.","year":"2020","unstructured":"Berntsen K.S.; Raastad T.; Marstein H.; Kirkhus E.; Merckoll E.; Cumming K.T.; Flat&#xF8; B.; Sjaastad I.; Sanner H.; Functional and structural adaptations of skeletal muscle in long-term juvenile dermatomyositis: a controlled cross-sectional study. Arthritis Rheumatol 2020,72(5),837-848","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Pediatric Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396317666210426105045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/193019\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396317666210426105045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T04:52:32Z","timestamp":1650430352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/193019\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":143,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573396317666210426105045","relation":{},"ISSN":["1573-3963"],"issn-type":[{"value":"1573-3963","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}